Enrollment of Clinical trial completed

We are pleased to announce that patient enrollment for the late phase 2 clinical trial, involving 402 subjects, has been completed.
Title: Safety and Efficacy of TU-100 as an Adjunct to an Enhanced Recovery After Surgery in Subjects Undergoing Bowel Resection

New videos uploaded.

Mechanism of Action of TU-100
Manufacturing process of Kampo product

TUI’s website launched

We have started posting about us, our group, and clinical trials.